These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 6817315)

  • 21. Vaccination against meningococcal disease.
    Lancet; 1970 Mar; 1(7648):663. PubMed ID: 4190641
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety of meningococcal polysaccharide vaccine serogroup "A" (Pilot Study).
    Bahl MR
    Med J Zambia; 1975 Dec-1976 Jan; 9(6):166. PubMed ID: 818845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A].
    Yuan CD
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682
    [No Abstract]   [Full Text] [Related]  

  • 24. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

  • 25. Statement on meningococcal vaccination for travellers. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine (CATMAT)
    Can Commun Dis Rep; 2009 Jun; 35(ACS-4):1-22. PubMed ID: 19526652
    [No Abstract]   [Full Text] [Related]  

  • 26. The epidemiology and control of invasive meningococcal disease.
    Diaz PS
    Pediatr Infect Dis J; 1999 Jul; 18(7):633-4. PubMed ID: 10440442
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
    Frøholm LO
    NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].
    Krízová P; Vlcková J; Bobák M
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to meningococcal meningitis.
    Sabath LD; Rosner B
    N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552
    [No Abstract]   [Full Text] [Related]  

  • 30. [Active immunization for prevention of meningococcal infections].
    Kardymowicz B; Rymkiewicz D
    Przegl Epidemiol; 1980; 34(2):193-201. PubMed ID: 6776590
    [No Abstract]   [Full Text] [Related]  

  • 31. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunological responses observed in field studies in Africa with group A meningococcal vaccines.
    Gotschlich EC; Rey M; Etienne J; Sanborn WR; Triau R; Cvjetanović B
    Prog Immunobiol Stand; 1971; 5():485-91. PubMed ID: 4633975
    [No Abstract]   [Full Text] [Related]  

  • 33. [Meningococcal disease in the Netherlands; after low tide another high tide?].
    Zanen HC
    Ned Tijdschr Geneeskd; 1984 Mar; 128(11):515-8. PubMed ID: 6424036
    [No Abstract]   [Full Text] [Related]  

  • 34. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Campaign against meningococcal meningitis. National vaccination program].
    Motta E
    Rev Bras Malariol Doencas Trop; 1977; 29():77-99. PubMed ID: 120953
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interpretation of the laboratory results concerning the protective effect of vaccines].
    Berrón Morato S; Sanz Moreno JC; Martín García E; Salcedo Peláez C; Bermúdez Saugar MP; Vázquez Moreno JA
    Rev Esp Salud Publica; 1998; 72(5):431-3. PubMed ID: 9951337
    [No Abstract]   [Full Text] [Related]  

  • 37. Meningococcal infections--what's next?
    Smith AL
    West J Med; 1989 Jan; 150(1):80-1. PubMed ID: 2499988
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vaccination Project-88. New Norwegian vaccine against type B meningitis--what happened?].
    Rød KA
    Fag Tidsskr Sykepleien; 1990 Jan; 78(1):27-31. PubMed ID: 2109367
    [No Abstract]   [Full Text] [Related]  

  • 39. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine research: new vaccines and evidence of vaccine safety.
    Commun Dis Rep CDR Wkly; 1999 May; 9(19):167, 170. PubMed ID: 10334064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.